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The search was refined by applying the limits ‘‘Humans’’
and ‘‘All adult: +19 years’’ in PubMed and searching within
the subject areas of physiology, respiratory system, cardio-
vascular system cardiology, sport sciences, and hematology in
the Web of Science. This initial search generated a group of
6775 references that were transferred to an EndNote (Thomson
Reuters, New York, NY) database.
In EndNote, duplicate references were removed. From
the remaining references in vitro, animal, or high altitude
natives studies, reviews and conference proceedings were
eliminated. The abstracts of the 446 remaining articles were
then independently evaluated by two researchers, and articles
not fulfilling the eligibility criteria (see next section) were
removed. Disagreements were resolved by involving the rest
of the research team. By this process, 53 articles were selected.
Subsequently, we built a reference map for each article and
obtained the references cited in or citing the initial 53 articles.
This step retrieved a new group of 3185 articles (1503 back-
ward and 1682 forward references), and the same process de-
tailed earlier and in Figure 1 was repeated. Finally, 66 articles
were selected to be included in the meta-analysis (see Sup-
plementary Digital Content, http://links.lww.com/MSS/A266).
Eligibility criteria. Any study on healthy humans report-
ing data before and after a period of exposure to hypoxia
(normobaric or hypobaric, continuous or intermittent) for
blood compartments (plasma volume, RCV, or blood volume)
or total hemoglobin mass was eligible. Only investigations
using direct methods of measurement (Evans blue, carbon
monoxide rebreathing, radioiodinated albumin, or brilliant red
dilution) were accepted. Studies in which the experimental
procedures included any intervention susceptible of affecting
any blood compartment, other than physical activity, were
eliminated as well.
Data extraction. The data were transferred into an
Excel file by two researchers working independently and
subsequently compared with avoid errors. When data were
extracted from the figures, the mean between the values
obtained by the two researchers was taken.
When altitude was not constant, a time-weighted average
was calculated.
Average altitude ¼ ~
n
i¼1Duri  Alti
Total duration
¼ Dur1  Alt1 þ Dur2  Alt2 þ Lþ Durn  Altn
Total duration
where Duri and Alti are the duration and altitude at step i.
So for, for example, a stepwise accent to Mount Everest
(24), the average altitude is derived as [1 d 3800 m + 5 d
4500 m + 5 d  5000 m + 2 d  5500 +I] / 36 d = 5720 m.
If only SEM values were reported, variance was calculated
from sample size and SD; otherwise, variance was calculated
from SD alone.
Statistical analysis. A mixed-model random-effects
meta-regression was performed (SAS 9.2; SAS Institute Inc.,
Cary, NC) on log-response ratios (12). The log-response ratio
was calculated as the logarithm to the change in RCV, that
is, the postvalue divided by the prevalue/control value. We
chose RCV as our effect parameter because of the linear
relationship with hemoglobin mass, whereas hematocrit and
hemoglobin concentrations were excluded for their depen-
dency on plasma volume. If RCV was not reported, it was
derived from hemoglobin mass according to a linear rela-
tionship derived from the 13 studies (n = 28) that reported
both hemoglobin mass and RCV (RCV = hemoglobin mass
2.899, P G 0.0001). In general, none of the included studies
reported confidence intervals or SD on the change in RCV;
rather, SD (or SEM) was reported on the pre- and postvalues
separately. Variance was therefore corrected as proposed for
crossover trials (5). P values G0.05 were considered statisti-
cally significant.
ANALYSIS AND RESULTS
Overall subject characteristics are reported in Table 1. In
total, this analysis reports data from 447 volunteers of which
376 were men and 71 women. RCV increases versus expo-
sure time and altitude are shown in Figure 1. Of the collected
data, 75% documented an increase in RCV, that is, an effect
size 90 regardless of statistical significance. Across the data
set, average RCV increase per week was 49 T 240 mLIwkj1.
Stratifying by exposure time, average RCV increases per
week were 37 T 81, 56 T 21, and 100 T 467 mLIwkj1 with
10, 20, and 28 d of exposure, respectively, across all altitudes.
For altitudes higher than 3000 m, the corresponding values
were 46 T 53, 46 T 258, and 188 T 466 mLIwkj1.
Heterogeneity. Because of the inclusion of articles
spanning different methods (plasma dye dilution, carbon
monoxide rebreathing, or radioactive albumin labeling), alti-
tudes (from 1300 to 6000 m above sea level), exposure times
(from 1 d to 1 yr), intermittent hypoxia (range 1–21 hIdj1,
mean 12 T 5 hIdj1), and normobaric hypoxia, data set het-
erogeneity is a potential confounder that might affect out-
come of the analysis (Table 2). We tested for inhomogeneity
FIGURE 1—Red blood cell response to exposure time and altitude.
Bubble sizes are scaled to log-response ratio and weighted according to
study sample size to preserve presentation fidelity transformed with
square root function. Filled bubbles indicate increased red cell increase,
and open bubbles indicate decreases.
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using a mixed-model regression analysis and found no sig-
nificant effect of the measurement method (P = 0.94),
normobaric versus hypobaric hypoxia (P = 0.68), continuous
versus intermittent hypoxia (P = 0.14), or exercise versus no
exercise (P = 0.23). Accordingly, all data were included in the
main analysis.
Effect of altitude and duration of exposure. For
clarity of presentation, data were divided into both altitude
and duration quartiles (see Fig. 2). The random effects model
yielded significant main effects for both altitude and duration
(both P G 0.0001, Fig. 1); however, there was also a signifi-
cant interaction effect (P G 0.0001), and therefore the main
effects (P values indicated) should be interpreted with cau-
tion. It seems that exposure time must exceed at least 2 wk at
an altitude of more than 4000 m to exert a significant effect.
At lower altitudes, even longer exposure times are needed
with altitudes lower than 3000 m not yielding a statistically
significant result within 4 wk.
We subsequently performed Monte Carlo simulation to
estimate the required exposure time for an increase in RCV
at different altitudes. We entered mean pre- and postexposure
RCV values with SD along with exposure time into a custom-
written Matlab (MathWorks, Natick, MA) procedure. From
these distributions, we randomly drew paired numbers and
calculated changes in RCV as a function of time. The results
of the simulation are presented in Table 3. There is an accel-
erating effect of increasing altitude so that, for example,
reaching a 10% increase at 2000 m will take 42 to 145 d,
whereas at 3500 m this can be achieved between 23 and 51 d.
Effect of initial RCV. Finally, we examined the effect
of the initial RCV on the RCV response to hypoxic expo-
sure. To obtain a homologous data set, that is, data obtained
with comparable exposure and methodology, we restricted
the analysis to the special case of exposure between 3000 and
3500 m and more than 7 d of stay. The random-effects model
showed a highly significant effect of initial RCV with a high
initial RCV showing less increase compared with low initial
RCV (P G 0.0001, Fig. 3).
DISCUSSION
The main findings of the meta-analysis and Monte Carlo
simulations are that altitude exposure must exceed 2 wk at an
altitude of 94000 m to exert a significant effect on RCV. At
lower altitudes, even longer exposure is required with alti-
tudes lower than 3000 m not yielding a statistically significant
result within 4 wk. Thus, we established an altitude dose–
response curve, indicating that the hypoxia-induced response
in RCV may be slower than widely expected (30).
Variation in RCV response. We found that the aver-
age RCV increase per week for our data was 49 T
240 mLIwkj1, which, on average, is in accordance with
previous findings with EPO administration (2). Although
we find the large variation surprising, similar results may be
found in the plasma Epo response to altitude. Ge et al. (10)
reported that the increase in plasma Epo after 24 h at 2800 m
varied markedly among individuals (n = 48), ranging from
TABLE 1. Volunteer characteristics.
5% 25% Median 75% 95%
Hematocrit (%) 39.7 42.4 44.3 46.0 46.8
Body weight (kg) 56.5 58.9 66.1 72.6 74.1
[Hb] (mmolILj1) 9.3 13.9 14.7 15.0 15.7
Hemoglobin mass (g) 654 733 868 988 1023
Per kg body weight 10.0 11.5 12.7 14.4 17.5
Plasma volume (mL) 2459 3019 3115 3536 4075
Per kg body weight 39.0 44.4 49.5 55.1 60.6
Red blood cell volume (mL) 1896 2125 2518 2864 2966
Per kg body weight 28.9 33.4 36.9 41.7 50.7
Total blood volume (mL) 4377 5410 5798 5979 7220
Per kg body weight 68.2 77.3 84.0 103.5 105.8
TABLE 2. No. data points entering the analysis depending on methodology.
N Pct.
CO
Rebreathing
Plasma Dye
Dilution
Radiolabeled
Albumin
Hypobaric
Hypoxia
Normobaric
Hypoxia
Continuous
Hypoxia
Intermittent
Hypoxia
CO rebreathing 67 44.1 — — — — — — —
Plasma dye dilution 56 36.8 — — — — — — —
Radiolabeled albumin 29 19.1 — — — — — — —
Hypobaric hypoxia 120 79.0 35 56 29 — — — —
Normobaric hypoxia 32 21.1 32 0 0 — — — —
Continuous hypoxia 111 73.0 31 52 28 111 0 — —
Intermittent hypoxia 41 27.0 36 4 1 9 32 — —
No exercise 92 60.5 22 52 18 92 0 91 1
Exercise 60 39.5 45 4 11 28 32 20 40
FIGURE 2—Red blood cell response. Data are presented in altitude
and exposure quartiles. Note that there was a significant interaction
between the effect of attitude and the exposure duration (P G 0.0001);
therefore, the main effects (P values indicated) should be interpreted
with caution. It is, however, clear that exposure time must exceed 17 d
at an altitude of more than 4000 m to exert a significant effect on the
oxygen carrying capacity of the blood. Data are weighted log-response
ratios with error bars indicating 95% confidence intervals.
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j41% to 400%, which seemed mainly governed by upstream
factors related to renal parenchymal PO2, although genetic
factors cannot be ruled out (19). Although variations in both
RCV and the Epo response to altitude are observed, these
do not seem to be interlinked. In a retrospectively analysis
(16), no correlation between EPO and erythropoietic response
was observed, which points to interindividual variation in
responsiveness (4). The Epo-induced expansion of RCV can
be used as a measuring stick for the speed of which RCV
expands at altitude. Previous findings with Epo suggest
that RCV expansion would not be expected to exceed
50 mLIwkj1 (2); however, we found that 935% of the
reported data correspond to RCV increases per week in ex-
cess of 50 mLIwkj1, and this finding is in accordance with
Sawka et al. (26). It is intriguing that, in some studies, an
increase in RCV is observed within days of exposure to
an altitude that did not stimulate polycythemia even after
weeks in other studies (Fig. 1). This suggests a substantial
interindividual variation (27). Other candidates that could lead
to variation include the use of different measurement tech-
niques or of the application of continuous versus intermittent
or normobaric versus hypobaric hypoxia (Table 2). Al-
though there was no systematic effect observed when these
parameters were entered as factors, the inclusion of re-
sults obtained with different methods may have increased
the variance and reduced the power of the analysis. Some
evidence suggests slightly different physiological responses
to hypobaric versus normobaric hypoxia about ventilation
and acute mountain sickness (18,22). However, this does
not seem to be the case for the RCV response, which is in
line with the observation that the Epo response to hypobaric
and normobaric hypoxia is also similar (7).
Effect of initial RCV. One factor that affected the re-
sponse to altitude exposure was the initial RCV. In this con-
text, we recently failed to observe an increase in RCV after
16 hIdj1 at 3000 m for 4 wk (27). From the analysis, we
would expect a 5%–10% increase in RCV, and we specu-
lated (25) that the absence of an increase in RCV could be
related to the high initial hemoglobin mass of the included
elite athletes that were at the upper end of physiological range
(Table 1). The present meta-analysis supports this approach
(Fig. 3). Although it is intuitively straightforward that an
upper limit to RCV expansion must exist, the physiological
mechanism governing such a limit is not as easily explained.
Although the current meta-analysis indicates that a high ini-
tial RCV limits a further expansion in hypoxia, the study by
Kapoor and Chatterjee (15) pointed out that despite a high
baseline level, an increase in RCV can still occur if dura-
tion and altitude are sufficient (Fig. 1). Thus, to what extent a
physiological upper limit to RCV exists is not clear from this
meta-analysis. However, 17.5 g of hemoglobin per kilogram
bodyweight has been reported in World and Olympic Cham-
pion cross-country skiers (14), which is markedly higher
than the values reported in healthy but untrained high alti-
tude Peruvians (8). Thus, the upper limit is likely not reached
by altitude exposure alone. It should thus be considered that
an RCV ceiling may not relate to increased oxygen carrying
capacity of blood alone. Any such ceiling could also be re-
lated to an upper limit in blood volume and thereby to blood
pressure regulation.
Another explanation for the finding that a high initial
RCV attenuates the further increase with hypoxic exposure
could be the statistical phenomenon of regression toward the
mean. Regression toward the mean may occur when RCV is
TABLE 3. Exposure time in days to obtain 95% probability for an increase in red blood cell volume.
Altitude
Both Continuous and Intermittent Hypoxia 2000 2500 3000 3500
1.00% 27 (21–39) 22 (18–32) 24 (18–31) 20 (12–38)
2.50% 35 (27–46) 25 (20–36) 26 (21–32) 20 (13–40)
5.00% 45 (33–60) 32 (28–44) 30 (26–38) 22 (17–41)
7.50% 59 (37–94) 42 (35–56) 33 (28–42) 23 (21–47)
10.00% 85 (42–145) 49 (39–116) 37 (31–46) 26 (23–51)
Only continuous hypoxia
1.00% 30 (24–44) 18 (14–23) 21 (13–28) 20 (12–40)
2.50% 38 (31–48) 20 (16–26) 21 (15–28) 21 (13–38)
5.00% 52 (37–72) 29 (22–34) 23 (19–30) 22 (17–41)
7.50% 69 (40–99) 34 (25–47) 24 (21–33) 23 (21–45)
10.00% 95 (47–141) 37 (28–49) 26 (23–37) 26 (22–52)
Monte Carlo simulation, 50,000 simulations; each altitude spans 375 m on each side of the midpoint. Numbers in parentheses are the 5th–95th percentile range.
FIGURE 3—The effect of initial hemoglobin mass on response to
hypoxic exposure. To ensure clarity of presentation and to avoid
confounding bias, data are limited to exposure times between 7 and 40 d
at altitudes between 3000 and 3500 m. On the abscissae, log-response
ratios with 95% confidence intervals are presented and on the ordinate
hemoglobin mass with SD. Mean values for altitude (3327, 3097, and
3070 m) and exposure (21, 19, and 23 d) for the three hemoglobin mass
groups (N = 13, 14, and 15) are not different.
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high on its first measurement because it will by chance tend to
be closer to the average on a second measurement. To avoid
drawing wrong conclusions from this meta-analysis (partic-
ularly Fig. 3), the possibility of regression toward the mean
should be considered. However, because regression toward
the mean is not based on cause and effect, but rather on
random error in a natural distribution around a mean, we
cannot exclude any underlying physiological mechanisms
influencing the effect of initial RCV on erythropoietic re-
sponse to altitude exposure.
Is altitude exposure relevant for athletes? To in-
crease RCV and thereby also sea-level exercise performance, it
is recommended that athletes reside in normobaric or hy-
pobaric hypoxia corresponding to an altitude of 2500–3000 m
for a minimum of 14 hIdj1 for 3 wk (30). The effect of the
initial RCV (Fig. 3) and the considerable time required to
establish an RCV response to medium altitude exposure
(Table 3) are of relevance for athletes considering engaging
into altitude training. Assuming that anecdotal reports of
athletes coping poorly with altitudes higher than 3000 m
(increased recovery period after exercise, poor quality of
sleep, etc.) are correct, then altitudes above this threshold
should be avoided. Because only studies in athletes who have
demonstrated 95% increase in hemoglobin mass after altitude
training generally report an increase in exercise performance
(25), it is recommended that athletes should spend sufficient
time at altitude to achieve a corresponding increase in he-
moglobin mass. A gain in hemoglobin mass of 7.5% re-
quires between 35 and 56 d of live high–train low or 25 to
47 d of continuous exposure at 2500 m to achieve a 995%
probability for an increase (Table 3). This may be further ex-
tended by a high initial RCV, which results in lower pro-
bability for a further increase to occur. This questions the
feasibility of altitude training for elite athletes, and the poten-
tial gains by altitude training, at least in athletes with a high
RCV starting point, should therefore be carefully reconsidered.
Publication bias. We found some indications of publi-
cation bias in the tendency for studies with small changes
and large variations to be missing from the analysis. Thus, we
cannot exclude that the analysis overestimates the positive
outcome. On the other hand, almost 40% of the included
data points reported negative findings and 50% of the data
points reported less than 2.5% increase.
Data set heterogeneity. Roughly a fourth of the data
originates from studies involving intermittent hypoxia
(Table 2). We were not able to detect any significant dif-
ferences when the two hypoxic exposures were compared
in the random-effects model. However, Monte Carlo anal-
ysis revealed that when the data obtained from intermittent
hypoxic exposure were removed from the analysis, time to
a 95% chance for an increase in RCV generally decreased
with 4–7 d, particularly around 3000 m above sea level where
most of the intermittent hypoxia studies were performed.
We also recorded iron supplementation, and in 72% of
the studies, no iron supplementation was performed.
Levine and Stray-Gundersen (17) suggested that iron
supplementation is needed only if iron stores are low.
Parisotto et al. (20) could not find an effect of iron supple-
mentation when Epo was administrated. Thus, iron avail-
ability may not be an issue for healthy individuals. However,
it is still not straightforward to access the impact of iron
supplementation as, for example, most studies with iron
supplementation use intermittent hypoxia. Thus, there is a
risk of covariance between the parameters. This extends to
possible differences between normobaric and hypobaric
hypoxia, sex, and methods used. In general, we saw no in-
dications that normobaric hypoxia was producing a different
response than hypobaric hypoxia, which is in accordance with
our recent findings (21). Likewise, we were not able to detect
any differences between the few studies reporting only women
and those with only men or a mixed population. What we
note, however, is that to our knowledge, no studies have
looked specifically at sex differences in RCV response to
altitude dwelling, and very few studies report males and fe-
males separately. Finally, the method to estimate RCV may
also introduce bias. According to Sawka el al. (26), CO
rebreathing may overestimate not only the RCV but also the
changes in RCV after altitude exposure because of CO loss to
myoglobin or other iron porphyrin molecules (i.e., in the
liver) and according changes in the quantity of these mole-
cules after altitude exposure. However, Gore et al. (11) and
Thomsen et al. (28) concluded that the two measurements
were equivalent. Furthermore, CO loss to myoglobin is as-
sumed minimal (1.6 mL for 10 min [9]), and even if myo-
globin should change because of altitude exposure, the effect
hereof on RCV must be assumed neglectable. Finally, it is
unknown if these extravascular iron molecules actually in-
crease with hypoxic exposure.
CONCLUSIONS
The physiological process of red cell expansion occurs
relatively slowly with only minor chances for an increase to
occur within 2 wk and exposure times longer than 4 wk gen-
erally required. Also, the accepted paradigm that altitudes
G3000 m are sufficient to trigger a robust RCV should be
reconsidered, particularly if the initial RCV is high. This, in
combination with a dependence on initial RCV, suggests that,
for example, athletes may need to spend more time at altitude
to see an effect on RCV than commonly recommended.
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